X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

DoKaSch Temperature Solutions and Japan Airlines sign Master Rental Agreement

Content Team by Content Team
13th July 2022
in Packaging & Logistic, Press Statements
DoKaSch Temperature Solutions and Japan Airlines sign Master Rental Agreement

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

DoKaSch Temperature Solutions and Japan Airlines (JAL) have signed a new Master Rental Agreement (MRA) for the usage of the temperature- controlled Opticooler as part of the cool service of the Japanese major carrier. The MRA opens up new possibilities to use the active Opticooler as a reliable and capable supply chain solution for pharmaceutical shipments to and from Asia. Therefore, DoKaSch and JAL meet the country’s growing needs for vaccine and pharmaceutical transportation in a safe and reliable way.

At Narita International Airport, Japan Airlines operates a hub at an airport that handles about 60% of Japan’s total pharmaceutical import trade. Furthermore, JAL’s intercontinental networks connect Japan with major hubs in Europe, North America, China, Southeast Asia as well as Australia. The new Master Rental Agreement with DoKaSch Temperature Solutions enables Japan Airlines to strengthen its cool chain capacities for its safe and fast pharma service providing forwarders and pharma producers with highly reliable packaging solutions. This makes Japan Airlines an important partner for the global supply of pharmaceutical products.

The Opticooler is a temperature-controlled packaging solution and comes in two sizes: the RAP container hold up to five euro-pallets, while the smaller RKN version provides space for one euro-pallet. Both active containers are battery-powered, can easily be adapted to any transport scenario, and enable customers to always keep the desired temperature level for example between two and eight degrees at any given time. Since the Opticoolers only require a power socket to be charged, they can easily be used as temporary storage when the necessary cool infrastructure is lacking. This makes them the ideal solution for the safe transport of highly sensitive pharmaceutical products which need to be protected from temperature deviations at all times.

Kiyoaki Yasui, Team leader, Cold Chain Logistics Team, of Japan Airlines stresses the importance of the agreement: “We have always focused on a strong cool chain within our network because the supply of lifesaving medicines is absolutely crucial. Thanks to direct connections to some of the most important hubs in Narita and Haneda, we can provide highly reliable and quick transports to a wide variety of destinations. The Opticoolers provided by DoKaSch Temperature Solutions are fulfilling our high standards and will support our extensive cool chain network in the Asia-Pacific region and beyond.”

Andreas Seitz, Managing Director of DoKaSch Temperature Solutions, adds: “The new Master Rental Agreement with Japan Airlines is an important addition to our partner network and significantly increases the availability of our Opticoolers in the Asia-Pacific region. Since especially Japan is an important producer of pharmaceutical products, reliable cool chain capacities in the greater region are of great importance. By providing our Opticoolers for these routes, we are able to support the supply with lifesaving medicines in the region as well as worldwide.”

Previous Post

Lonza To Construct $518mn Fill-Finish Plant In Switzerland

Next Post

Indian Pharma Business May Increase 8-11%, Predicts Alkem

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
Future Trends Shaping
Packaging & Logistic

Future Trends Shaping Pharma Supply Chain and Logistics

30th July 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Next Post
Indian Pharma Business May Increase 8-11%, Predicts Alkem

Indian Pharma Business May Increase 8-11%, Predicts Alkem

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In